LESTER RACHAEL (Chief Business Officer) received a stock award from CYTOMX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2026ACC: 0001610717-26-000043
Officer· Chief Business Officer
Since Feb 2026
+120K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
120K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
New position
2/2/2026
0.00→20K
Total
Net shares
+20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +20K | — | — | New position | 0.00 | 20K |
| Total | +20K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
6.09
Held after
50K
Exercisable
—
2/2/2026
Performance Stock Units (PSUs)
Direct
Converts to
Common Stock
50K shares
Shares
+50K
Strike price
Held after
50K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 2/2/2026 | A · Award | +50K | 6.09 | — | 50K |
| Performance Stock Units (PSUs) Direct | Common Stock50K shares | 2/2/2026 | A · Award | +50K | — | 50K |